|
TPP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.9960036108132E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12652118136702E-12 |
| Normal-vs-Stage2 |
1.52806000000005E-05 |
| Normal-vs-Stage3 |
1.67220004509971E-09 |
| Normal-vs-Stage4 |
6.57019993965946E-10 |
| Stage1-vs-Stage2 |
8.094000E-01 |
| Stage1-vs-Stage3 |
5.535800E-01 |
| Stage1-vs-Stage4 |
3.195100E-03 |
| Stage2-vs-Stage3 |
8.615400E-01 |
| Stage2-vs-Stage4 |
5.186000E-02 |
| Stage3-vs-Stage4 |
3.666400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69864122767649E-14 |
| Normal-vs-AfricanAmerican |
3.64000000000475E-05 |
| Normal-vs-Asian |
2.56910000051569E-07 |
| Caucasian-vs-AfricanAmerican |
5.233800E-01 |
| Caucasian-vs-Asian |
7.560600E-01 |
| AfricanAmerican-vs-Asian |
7.114000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80619996736908E-09 |
| Normal-vs-Female |
1.63125069008174E-12 |
| Male-vs-Female |
7.140200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32870381364114E-11 |
| Normal-vs-Age(41-60Yrs) |
1.05290220986376E-11 |
| Normal-vs-Age(61-80Yrs) |
2.84219980883904E-10 |
| Normal-vs-Age(81-100Yrs) |
5.634400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.286400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.235000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.605800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.090000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.732200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.662840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.541600E-02 |
| Classical-VS-Follicular |
5.131700E-02 |
| Classical-VS-Other |
2.474800E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
3.304400E-03 |
| Tall-VS-Other |
1.913800E-01 |
| Tall-VS-Normal |
4.89440044049161E-10 |
| Follicular-VS-Other |
8.023400E-01 |
| Follicular-VS-Normal |
1.768640E-04 |
| Other-VS-Normal |
3.540000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.69510011267016E-11 |
| Normal-vs-N1 |
3.25410000001636E-06 |
| N0-vs-N1 |
9.455600E-01 |
|
|
